[A Case of Colon Cancer with Suspected DPD Deficiency Causing Severe Adverse Effects following Adjuvant Chemotherapy with Capecitabine].

Author: AokiHideki, ArakiHiroyuki, ArataTakashi, KatsudaKo, KimuraYuji, MinagiHitoshi, NagahisaSeiichi, OgawaToshihiro, TanakayaKoji, TaniguchiFumitaka, WatanabeMegumi

Paper Details 
Original Abstract of the Article :
The present study reports a case of colon cancer in a 76-year-old female who underwent laparoscopic right colectomy. Pathological findings revealed pT3(SS), pN2a, cM0, and pStage Ⅲb. Hence, we administered adjuvant chemotherapy with capecitabine. On day 18, she was urgently hospitalized because of s...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/35045450

データ提供:米国国立医学図書館(NLM)

A Case of Colon Cancer and DPD Deficiency: Navigating a Complex Medical Journey

Colon cancer is a formidable foe, and finding effective treatment strategies requires careful navigation through a complex medical landscape. This study presents a case of a 76-year-old woman who underwent surgery for colon cancer and subsequently experienced severe adverse effects during adjuvant chemotherapy with capecitabine. The researchers suspected a deficiency in dihydropyrimidine dehydrogenase (DPD), an enzyme crucial for metabolizing capecitabine, as the underlying cause of the complications.

DPD Deficiency: A Hidden Obstacle in Colon Cancer Treatment

This case study highlights the importance of recognizing and managing DPD deficiency, a potential complication of capecitabine therapy. The study emphasizes the need for careful patient selection and appropriate monitoring to prevent severe adverse effects and ensure optimal treatment outcomes.

Navigating the Terrain of Colon Cancer Treatment: A Cautionary Tale

This study serves as a reminder of the complexities of cancer treatment, especially in the context of genetic variations like DPD deficiency. The case highlights the need for a multidisciplinary approach, including genetic testing and individualized treatment plans, to ensure patient safety and optimal treatment outcomes.

Dr. Camel's Conclusion

Just as a camel adapts its journey through the desert to navigate treacherous terrain, we must be aware of potential roadblocks in cancer treatment. This case study underscores the importance of understanding individual patient characteristics and tailoring treatment strategies to ensure a safe and effective journey.

Date :
  1. Date Completed 2022-01-21
  2. Date Revised 2022-01-21
Further Info :

Pubmed ID

35045450

DOI: Digital Object Identifier

35045450

Related Literature

SNS
PICO Info
in preparation
Languages

Japanese

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.